Tags

Vitiligo Treatment

Lynk Pharmaceuticals receives NMPA approval for Phase II trial of LNK01004 ointment

Lynk Pharmaceuticals receives NMPA approval for Phase II trial of LNK01004 ointment

June 01, 2026 | 14:47
Lynk Pharmaceuticals announced that China's NMPA approved its Phase II clinical trial of LNK01004 ointment for treating vitiligo and chronic hand eczema.

Latest News

Vietnam and Philippines upgrade ties to Enhanced Strategic Partnership

Vietnam and Philippines upgrade ties to Enhanced Strategic Partnership

Bank credit sustains livelihoods on Ly Son Island

Bank credit sustains livelihoods on Ly Son Island

Vietnamese manufacturers record a rebound in new orders in May

Vietnamese manufacturers record a rebound in new orders in May

BEYOND Expo 2026 showcases emerging Asian technology in Macao

BEYOND Expo 2026 showcases emerging Asian technology in Macao

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society Swing for the Kids CSR
World News
virs-publications-vir
timeout-vn
ptbv2020